ITW to Present at Upcoming Investor Events
Oct 16, 2017 12:01 pm UTC| Business
GLENVIEW, Ill., Oct. 16, 2017 -- Illinois Tool Works Inc. (NYSE:ITW) announced the following investor events: Vice Chairman, Christopher A. O’Herlihy, and Senior Vice President and Chief Financial Officer, Michael M....
Telefonica Deploys ASSIA’s GPON Expresse® Solution to optimize Fiber Broadband Performance
Oct 16, 2017 12:01 pm UTC| Business
REDWOOD CITY, Calif., Oct. 16, 2017 -- Adaptive Spectrum and Signal Alignment, Inc. (ASSIA®). ASSIA and Telefonica announce widespread deployment of ASSIA’s GPON Expresse® software across countries in South America:...
3rd Annual October Fest to be Held at Holiday Island Shopping Center
Oct 16, 2017 12:01 pm UTC| Business
HOLIDAY ISLAND, Ark., Oct. 16, 2017 -- Holiday Island Holdings, Inc. (OTC Pink:HIHI) – a development stage company operating in the land development sector of the market – released the news today that the 3rd Annual...
Saama Expands Further and Makes Its Presence Felt in the Pharma Capital
Oct 16, 2017 12:01 pm UTC| Business
CAMPBELL, Calif., Oct. 16, 2017 -- Saama Technologies, Inc., a leading clinical analytics company, has opened a new office in Bridgewater, New Jersey. This new office space brings the company closer to its current and...
Albireo to Host KOL Event on Progressive Familial Intrahepatic Cholestasis
Oct 16, 2017 12:01 pm UTC| Business
BOSTON, Oct. 16, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that it will host a Key Opinion Leader (KOL)...
Extendicare Announces October 2017 Dividend of C$0.04 per Share
Oct 16, 2017 12:01 pm UTC| Business
MARKHAM, Ontario, Oct. 16, 2017 -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month...
Oct 16, 2017 12:01 pm UTC| Business
AUSTIN, Texas, Oct. 16, 2017 -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases...